Switch to:
More From Other Websites
GlaxoSmithKline LLC -- Moody's changes outlook on GSK's A2 issuer rating to negative May 29 2015
Glaxo Bulls Awaken With Calls as Pfizer Merger Chatter Escalates May 29 2015
Glaxo Bulls Awaken as Pfizer Merger Chatter Escalates May 29 2015
Why I’m Bullish On GlaxoSmithKline plc, Interserve plc And Carillion plc May 27 2015
ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of... May 26 2015
Innovation and scale fuel growth in Big Pharma May 24 2015
Investors prepared to give Sir Andrew Witty time to revive GSK May 24 2015
Would Pfizer Buying GlaxoSmithKline Make Sense? May 22 2015
Who are Gilead Sciences' (GILD) main competitors? May 22 2015
Which Is The Better Pick For Your Portfolio: GlaxoSmithKline plc Or AstraZeneca plc? May 22 2015
GSK submits Japan regulatory application for mepolizumab in severe eosinophilic asthma May 22 2015
All Eyes on Pfizer as Shareholders Await the Mega-Deal: Real M&A May 21 2015
How a "PfizerKline" would impact the Triangle May 21 2015
$5.6B In Fines Against Major Banks Seems Like A Lot. Here's Why It Won't Deter Corporate Crime. May 20 2015
Takeover talk sends FTSE higher May 20 2015
GSK unmoved by broker talk of takeover May 20 2015
Pfizer Would Benefit From Glaxo Takeover, Deutsche Bank Says May 20 2015
What This Top Dividend Portfolio Is Holding Now: GlaxoSmithKline plc, Royal Dutch Shell Plc And... May 20 2015
New Study Shows Inner-City Asthma Care Program Reduces Student Absenteeism by up to 20 Percent May 19 2015
3 Stocks That Should Keep Delivering The Goods: GlaxoSmithKline plc, Lloyds Banking Group PLC &... May 19 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK